Study on Development and Evaluation of Mobile App "Health Care Ceo" for Patients with Type 1 Diabetics Aged 16-25: Continued Research Project (1)

Background and Purpose: Sixteen to twenty-five year-old patients with type 1 diabetes face multiple shifts in their career and development, and deterioration in disease control to cause rapid exacerbation, which not only leads to early onset of further complications, but also affects quality of life. Providing patients with intervention to meet their needs can reduce the impact during the transition period. The transitional research project implemented by our team showed that to develop a specific mobile APP is a very important heath care needs with high consensus among patient, parents and health care provider. Therefore, we are developing a mobile APP based on the ISR theory, and it is expected to be completed by July 31, 2020. Monitoring of treatment fidelity is essential to ensuring success and consistency for interventional study, this extension project thus aims to evaluate “Healthcare CEO.” mobile APP for patients with type 1 diabetes aged 16-25, with monitor treatment fidelity.Method: This 2-year longitudinal, randomized control study intends to enroll 16-25-year-old patients with type 1 diabetes at outpatient clinics and wards of the Division of Pediatrics and the Division of Adult Metabolism in a medical center in northern Taiwan, with 120 subjects expected to be enrolled. The subjects will be divided randomly into experimental group or comparison group. This study will develop strategies to enhance treatment fidelity and then compared the outcome of the two groups, in disease control, confidence in self-management, self-care behaviors, emotional disturbance, quality of life and knowledge after 3,6,9 months, thereby evaluating the intervention of "Health Care CEO." The findings will provide as important references for clinical practice.

Project ID:PC10907-1161
External Project ID:MOST109-2314-B182-057-MY2